BIOXELL

bioxell-logo

BioXell was founded in 2002 as a spinout of Roche Milano Ricerche, a leading biomedical research institute created ten years earlier that focused on chronic inflammatory disease and autoimmunity. The idea to create BioXell originated with Francesco Sinigaglia, founder and director of the Milan-based research institute, following a scientific career path that took him to the University College in London, the Basel Institute of Immunology and the Hoffmann-La Roche research units in Basel. Dr. Sinigaglia, former CEO, approached Roche with his challenging project and a year later BioXell was spun off, with $22m invested by MPM Capital, Index Ventures and Life Science Partners.

#People #Financial #Website #More

BIOXELL

Social Links:

Industry:
Association Biotechnology Education Medical

Founded:
2002-01-01

Address:
Milan, Lombardia, Italy

Country:
Italy

Website Url:
http://www.bioxell.com

Total Employee:
1+

Status:
Active

Contact:
+39 02 21049 51

Email Addresses:
[email protected]

Total Funding:
72.5 M EUR

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Google Universal Analytics Amazon Organization Schema



Current Advisors List

hubert-birner_image

Hubert Birner Board of Directors(Milan, Italy) @ BioXell
Board_member

Current Employees Featured

not_available_image

Niels Ackermann
Niels Ackermann CEO @ BioXell
CEO

not_available_image

Laurence H. Skillern
Laurence H. Skillern CFO @ BioXell
CFO

not_available_image

Alvise Sagramoso
Alvise Sagramoso CAO @ BioXell
CAO

Stock Details


Company's stock symbol is SWX:BXLN

Investors List

mvm-life-science-partners_image

MVM Life Science Partners

MVM Life Science Partners investment in Series C - BioXell

tvm-capital_image

TVM Capital

TVM Capital investment in Series C - BioXell

index-ventures_image

Index Ventures

Index Ventures investment in Series C - BioXell

bb-biotech-ventures_image

BB Biotech Ventures

BB Biotech Ventures investment in Series C - BioXell

index-ventures_image

Index Ventures

Index Ventures investment in Series C - BioXell

mvm-life-science-partners_image

MVM Life Science Partners

MVM Life Science Partners investment in Series C - BioXell

alpinvest-partners_image

AlpInvest Partners

AlpInvest Partners investment in Series C - BioXell

mpm-capital_image

MPM Capital

MPM Capital investment in Series C - BioXell

nif-ventures_image

NIF Ventures

NIF Ventures investment in Series C - BioXell

bb-biotech-ventures_image

BB Biotech Ventures

BB Biotech Ventures investment in Series C - BioXell

Official Site Inspections

http://www.bioxell.com

  • Host name: vwp1380.webpack.hosteurope.de
  • IP address: 87.230.105.136
  • Location: Germany
  • Latitude: 51.4476
  • Longitude: 7.0122
  • Timezone: Europe/Berlin

Loading ...

More informations about "BioXell"

BioXell - Crunchbase Company Profile & Funding

BioXell is a biomedical research institute focusing on chronic inflammatory disease and autoimmunity.See details»

OUR LEADERSHIP - bioxell.com

The spirit of collaboration that characterizes our distinctive corporate culture is present both within the organization and with external stakeholders. Openness and a strong sense of teamwork โ€ฆSee details»

Bioxell GmbH โ€ข Reserach and Development of Cell Line โ€ฆ

Bioxell is a leading, innovation-driven company specializing in the development of cell line and proteinfs.See details»

BioXell S.p.A. - Mailand, Italy

Mar 3, 2010 BioXell was founded in 2002 as a spinout of Roche Milano Ricerche, a leading biomedical research institute created ten years earlier that focused on chronic inflammatory โ€ฆSee details»

About Us โ€ข Bioxell GmbH

The main focus of our production is the manufacturing of high quality Monoclonal and polyclonal antibody development and Peptide Synthesis for biotech, diagnostic and research โ€ฆSee details»

BioXell - Funding, Financials, Valuation & Investors

BioXell is a biomedical research institute focusing on chronic inflammatory disease and autoimmunity.See details»

BioXell - PitchBook

Information on acquisition, funding, cap tables, investors, and executives for BioXell. Use the PitchBook Platform to explore the full profile.See details»

BioXell - Crunchbase Company Profile & Funding

Bioxell is an Egyptian pharmaceutical company specialized in contract manufacturing and marketing high-quality pharmaceuticals and health care products. The company was founded 2007 in Cairo, Egypt by Hisham Aggour, โ€ฆSee details»

BioXell (Group) - life-sciences-europe.com

Jan 1, 2002 BioXell (SWX: BXLN) is a biopharmaceutical company focused on the discovery and development of drugs that exploit novel mechanisms of action to treat important โ€ฆSee details»

BioXell - Products, Competitors, Financials, Employees, โ€ฆ

BioXell S.p.A. BioXell is a biopharmaceutical company focused on the discovery and development of drugs that exploit novel mechanisms of action to treat important urological, inflammatory, โ€ฆSee details»

BioXell: an Italian biotech success story? - Nature

Sep 1, 2006 BioXell's decision to seek a listing in Zürich rather than its hometown of Milan underlines the lack of development of a fully fledged investment infrastructure for Italian biotech.See details»

Vision and Strategy - Bioxell GmbH

Serving the needs of biologists The goal of Bioxell is to create high-quality, innovative goods and services. We are dedicated to providing for the present and foreseeable needs of researchers โ€ฆSee details»

BioXell SpA - Overview, News & Competitors | ZoomInfo.com

View BioXell SpA (www.bioxell.com) location in New Jersey, United States , revenue, industry and description. Find related and similar companies as well as employees by title and much more.See details»

BioXell - Contacts, Employees, Board Members, Advisors & Alumni

BioXell is a biomedical research institute focusing on chronic inflammatory disease and autoimmunity.See details»

NEWS_NBT0906.indd - Nature

BioXellโ€™s decision to seek a listing in Zürich rather than its hometown of Milan underlines the lack of development of a fully fledged investment infrastructure for Italian bio-tech. In a ...See details»

Antibodies for In Vivo Research | Bio X Cell

InVivo Plus TM Antibodies Exceed strict demands and rigorous standards required for in vivo work at any research organization.See details»

BioXell acquired by Cosmo Pharmaceuticals - Crunchbase

Nov 18, 2009 BioXell BioXell is a biomedical research institute focusing on chronic inflammatory disease and autoimmunity.See details»

Cell Services โ€ข Bioxell GmbH

Our highly skilled scientific experts provide a one-stop-shop from cloning to development of stable cell lines or GMP-compliant Research Cell Banks (RCB).See details»

BioXcel Therapeutics Inc โ€“ BioXcel Therapeutics Inc

Nov 22, 2024 All other trademarks are the properties of their respective owners. Copyright © 2023 BioXcel Therapeutics Inc. All Rights Reserved. US-IGA-2300177See details»

Protein Services - Bioxell GmbH

Our experienced scientific specialists provide high quality recombinant protein expression and purification services tailored to your specific needs.See details»

linkstock.net © 2022. All rights reserved